217 related articles for article (PubMed ID: 10823749)
1. A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia.
Hayashi J; Furusyo N; Ariyama I; Sawayama Y; Etoh Y; Kashiwagi S
J Infect Dis; 2000 May; 181(5):1523-7. PubMed ID: 10823749
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection.
Hayashi J; Kishihara Y; Yamaji K; Furusyo N; Yamamoto T; Pae Y; Etoh Y; Ikematsu H; Kashiwagi S
Hepatology; 1997 Mar; 25(3):697-701. PubMed ID: 9049221
[TBL] [Abstract][Full Text] [Related]
3. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
Tokita H; Murai S; Kamitsukasa H; Yagura M; Harada H; Takahashi M; Okamoto H
J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
[TBL] [Abstract][Full Text] [Related]
5. Relationship of hepatitis C virus genotypes and viremia levels with development of hepatocellular carcinoma among Japanese.
Tanaka K; Hirohata T
Fukuoka Igaku Zasshi; 1998 Aug; 89(8):238-48. PubMed ID: 9778916
[TBL] [Abstract][Full Text] [Related]
6. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
[TBL] [Abstract][Full Text] [Related]
7. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
[TBL] [Abstract][Full Text] [Related]
8. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
9. Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.
Rino Y; Tarao K; Morinaga S; Ohkawa S; Miyakawa K; Hirokawa S; Masaki T; Tarao N; Yukawa N; Saeki H; Takanashi Y; Imada T
Anticancer Res; 2006; 26(3B):2221-6. PubMed ID: 16821591
[TBL] [Abstract][Full Text] [Related]
10. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
Moriyama M; Matsumura H; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Goto I; Tanaka N; Arakawa Y
Liver Int; 2005 Feb; 25(1):85-90. PubMed ID: 15698403
[TBL] [Abstract][Full Text] [Related]
11. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities.
Silini E; Bono F; Cividini A; Cerino A; Bruno S; Rossi S; Belloni G; Brugnetti B; Civardi E; Salvaneschi L
Hepatology; 1995 Feb; 21(2):285-90. PubMed ID: 7843695
[TBL] [Abstract][Full Text] [Related]
12. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
De Mitri MS; Cassini R; Morsica G; Bagaglio S; Andreone P; Loggi E; Muratori P; Bernardi M
J Viral Hepat; 2006 Sep; 13(9):574-81. PubMed ID: 16907843
[TBL] [Abstract][Full Text] [Related]
13. Variation of hepatitis C virus load, hypervariable region 1 quasispecies and CD81 hepatocyte expression in hepatocellular carcinoma and adjacent non-cancerous liver.
Young KC; Lin PW; Hsiao WC; Chang TT; Chang YC; Wu HL
J Med Virol; 2002 Oct; 68(2):188-96. PubMed ID: 12210407
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C.
McCormick SE; Goodman ZD; Maydonovitch CL; Sjogren MH
Am J Gastroenterol; 1996 Aug; 91(8):1516-22. PubMed ID: 8759653
[TBL] [Abstract][Full Text] [Related]
15. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus genotypes in patients with hepatocellular carcinoma.
Akkiz H; Colakoğlu S; Köksal F; Korkut H; Hafta A
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):85-8. PubMed ID: 9216790
[TBL] [Abstract][Full Text] [Related]
17. Relationship between infection with hepatitis C virus and hepatocellular carcinoma in Japan.
Iino S
Antivir Ther; 1998; 3(Suppl 3):143-6. PubMed ID: 10726064
[TBL] [Abstract][Full Text] [Related]
18. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
19. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
20. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.
Aizawa Y; Shibamoto Y; Takagi I; Zeniya M; Toda G
Cancer; 2000 Jul; 89(1):53-9. PubMed ID: 10897000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]